Mail

MJNA - Medical Marijuana, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

0.0564

-0.0009 (-1.57%)

At close: 3:59PM EDT

Stock chart is not supported by your current browser

Previous Close	0.0573
Open	0.0600
Bid	0.0000 x 0
Ask	0.0000 x 0
Day's Range	0.0550 - 0.0600
52 Week Range	0.0400 - 0.1200
Volume	4,523,216
Avg. Volume	8,678,314

Market Cap	207.018M
Beta (3Y Monthly)	-1.93
PE Ratio (TTM)	N/A
EPS (TTM)	-0.0160
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Trade prices are not sourced from all markets

All

News

Press Releases

Yahoo Finance Video19 days ago
Path to marijuana legalization in the U.S.
The FDA is holding a hearing today to look into the science and safety of products containing cannabis and CDB. Stuart Titus, Medical Marijuana Inc CEO, is attending the hearing, and joins Yahoo Finance with his take.
PR Newswire5 days ago
Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies, Inc. Moves Forward on Oral Healthcare Line With Cannabinoid Product Supply Agreement
SAN DIEGO , June 13, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC:MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever ...
PR Newswire6 days ago
Medical Marijuana, Inc. Announces Completion of the First-Ever High-Level Stability Study on a CBD Hemp Oil Product
SAN DIEGO, June 12, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company has reached a major milestone for long-term stability testing on its flagship THC-free cannabidiol (CBD) oil product Real Scientific Hemp Oil-X™ (RSHO-XTM). "We're excited to offer consumers and retail partners the transparency and security of knowing that our products are reliable and stable throughout several climatic conditions and through transportation," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. This helps the company ensure to its customers and retailers that the integrity of the product will not be compromised while in transportation or while being stored for future use," said Medical Marijuana, Inc. Vice President of Project Analysis and R&D, Dr. Levan Darjania.
ACCESSWIRE8 days ago
Medical Marijuana, Inc. joins The Stock Day Podcast to Discuss Major Accomplishments for 2019
PHOENIX, AZ / ACCESSWIRE / June 10, 2019 / The Stock Day Podcast welcomed Medical Marijuana, Inc. (OTC PINK: MJNA) ("the Company"), a cannabis company with three distinct business units in the non-psychoactive cannabinoid space. President and CEO, Dr. Stuart Titus, joined Stock Day host Everett Jolly. Jolly began the interview by asking about the Company's recent FDA hearing.
PR Newswire13 days ago
Medical Marijuana, Inc. Subsidiary HempMeds® Adds New CBD-Infused Products to Personal Care Line
Research firm Jeffries estimates that the CBD beauty category could reach $25 billion globally and will amass 15 percent of the total skin care market within the next decade. "We have a long history of being a pioneer in the CBD industry and want to continue to be recognized as a leader in industry trends with these new products," said HempMeds® President Todd Morrow. HempMeds® Personal Care Line initially launched in April 2019 on International Women's Day and due to the positive response the company received about these products and feedback from customers who were looking for more topical options, HempMeds® made the strategic decision to add a Soothing Body Balm, a revitalized version of HempMeds® Active Relief Roll-On, and an Essential Body Oil.
PR Newswire15 days ago
Medical Marijuana, Inc. Announces International Coverage at FDA Public Hearing on Cannabis and CBD Products
SAN DIEGO, June 3, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that Dr. Stuart Titus, the Company's Chief Executive Officer, was featured in several national and international news publications about his speaking engagement at the U.S. Food and Drug Administration (FDA) Hearing on cannabis and cannabidiol (CBD) on Friday, May 31, 2019. Just last year, Medical Marijuana, Inc. saw a year-over-year revenue increase of more than 125% over 2017. Also, the Brightfield Group stated in its 2018 Annual Report that the CBD market is expected to grow by nearly 40 times within the next four years, outpacing the rest of the cannabis market, including Tetrahydrocannabinol (THC) marijuana products, to reach $22 billion by 2022.
Yahoo Finance18 days ago
Marijuana CEO: 'Many of us are cannabinoid deficient'
Medical Marijuana Inc (MJNA) CEO Stuart Titus is optimistic about the effects that cannabis-derived products have on humans.
PR Newswire19 days ago
Medical Marijuana, Inc. Subsidiary HempMeds® Launches New Everyday Wellness Functional CBD Solutions Product Line
SAN DIEGO , May 30, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever ...
PR Newswire20 days ago
Medical Marijuana, Inc. CEO to Present on CBD Safety at Sixth Annual New York Cannabis World Congress; Subsidiary HempMeds® to Exhibit New CBD Products
SAN DIEGO, May 29, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company's CEO Dr. Stuart Titus will speak on medical cannabis and cannabidiol (CBD) safety at the Sixth Annual Cannabis World Congress & Wellness Expo in New York on May 30-June 1. The Company's subsidiary HempMeds® will be exhibiting at the conference and will be launching a new CBD product line.
PR Newswire21 days ago
Medical Marijuana, Inc. Subsidiary Kannaway® Announces First-Ever Authorization in Bulgaria to Sell Hemp-Derived CBD Products
SAN DIEGO, May 28, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that it has received the first-ever authorization in Bulgaria to sell hemp-derived cannabidiol (CBD) products. "As the EU continues to navigate its stance on CBD, we are proud to continue paving the way for the acceptance of CBD in Bulgaria just as we have in many other countries around the world," said Kannaway® CEO Blake Schroeder. This authorization certifies that Kannaway®'s imported goods are normally and freely sold in the certifying country's open markets and are approved for export.
PR Newswire26 days ago
Medical Marijuana, Inc. Portfolio Company Kannalife, Inc. Publishes New Research on CBD and Chemotherapy-Induced Peripheral Neuropathy
SAN DIEGO , May 23, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever ...
PR Newswire27 days ago
Medical Marijuana, Inc. Reports Over $20.2M in Revenue in Q1 2019, Up 92% Year-Over-Year in Financial Results
SAN DIEGO , May 22, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , announced today its financial results for the quarter ...
PR Newswire28 days ago
Medical Marijuana, Inc. CEO Chosen to Present Oral Comments at FDA's Public Hearing on Products Containing Cannabis and Cannabis-Derived Compounds
SAN DIEGO, May 21, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, announced today that the Company's CEO, Dr. Stuart Titus, has been chosen as one of 65 speakers to present oral comments at the U.S. Food & Drug Administration (FDA)'s upcoming public hearing discussing scientific data and information about products containing cannabis-derived compounds. Titus was chosen from nearly 400 applicants and will give his oral comments between 8:00 a.m. and 10:30 a.m. on Friday, May 31, 2019. "I'm honored to be given this opportunity to speak on a national stage about why cannabidiol (CBD) as derived from industrial hemp and in its botanical form, should be allowed as a dietary supplement and food ingredient.
Market Exclusivelast month
Cannabis Stock News Daily Roundup May 15
GrowGeneration (OTCQX: GRWG) has purchased the assets of GreenLife Garden Supply, including two locations in Maine and one in New Hampshire. The acquisition brings the company's total retail and warehouse locations to five that services the growing number of commercial cultivators in the New England market. Target Group (OTCQB: CBDY) subsidiary Canary Rx has submitted a site […]The post Cannabis Stock News Daily Roundup May 15 appeared first on Market Exclusive.
PR Newswirelast month
Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Launches New Natural Orange-Flavored CBD Tincture
SAN DIEGO , May 15, 2019 /PRNewswire/ -- Medical Marijuana, Inc . (OTC: MJNA), the first publicly traded cannabis company in the United States , announced today that its subsidiary Dixie Botanicals® ...
PR Newswirelast month
Medical Marijuana, Inc. Major Investment Company Axim® Biotechnologies Files New U.S. Provisional Patent for Cannabis Gum as a Treatment for Migraine Symptoms
NEW YORK , May 14, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that the Company's major investment ...
PR Newswirelast month
Medical Marijuana, Inc. Announces April 2019 as the Largest Sales Bookings Month in Company History
SAN DIEGO , May 9, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that the company had its the largest-ever ...
PR Newswirelast month
Medical Marijuana, Inc. Subsidiary Kannaway® Unveils New CBD Coffee and Tea Pods
SAN DIEGO , May 7, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that its subsidiary Kannaway® has released ...
Benzinga2 months ago
Top 10 New Studies On The Effects of Marijuana
It’s been an exciting 12-months for cannabis research. Every year, researchers discover more about marijuana and its effects. Brief Overview: After comparing the hospital records of more than a million heart-attack patients, researchers from the University of Colorado discovered that those who had used cannabis in the past were significantly less likely to die during hospitalization.
PR Newswire2 months ago
Medical Marijuana, Inc. Subsidiary Kannaway® Honored as Gold Stevie® Award Winner in 2019 American Business Awards®
SAN DIEGO, May 2, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) announced today that its subsidiary Kannaway®, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, was named the winner of a Gold Stevie® Award in the Medium Company of the Year - Health Products & Services category in The 17th Annual American Business Awards®. The American Business Awards are the U.S.A.'s premier business awards program. More than 200 professionals worldwide participated in the judging process to select this year's Stevie Award winners.
PR Newswire2 months ago
Medical Marijuana, Inc. Subsidiary Kannaway® Listed Among Top 100 Direct Selling Companies in the World
SAN DIEGO, April 30, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) announced today that its subsidiary Kannaway®, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has been recognized by Direct Selling News as one of the top revenue-generating direct selling companies on the 2019 DSN Global 100 list. Direct Selling News created the Global 100 list to acknowledge the successes of direct selling companies and showcase the size of the industry.
PR Newswire2 months ago
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Hosts International Symposium on Cannabinoid Medicine for Brazilian Doctors in San Diego
SAN DIEGO, April 29, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil is hosting an International Symposium on Cannabinoid Medicine on April 29 - May 1, 2019 in San Diego, California for a group of medical doctors from Brazil. At the event, nine world-renowned Brazilian medical doctors and a biomedicine scientist will gather in San Diego for a three-day event to learn about the potential therapeutic applications of cannabidiol (CBD) and about the significant research taking place in San Diego for several conditions such as epilepsy and autism.
PR Newswire2 months ago
Medical Marijuana, Inc. Subsidiary Kannaway® Sports Team Welcomes Professional Boxer Austin Dwayne Trout
SAN DIEGO, April 25, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary Kannaway® has welcomed American professional boxer Austin Dwayne Trout as a spokesperson for the company to help spread awareness on the benefits of hemp cannabidiol (CBD) for athletes and active consumers. "We are excited to have someone on our team who is so excited about furthering our mission of spreading education on the potential wellness benefits of CBD," said Kannaway® CEO Blake Schroeder.
PR Newswire2 months ago
Medical Marijuana, Inc. Subsidiary Phyto Animal Health Adds HempBone Smoked Salmon Bites for Cats to CBD Pet Product Line
SAN DIEGO , April 24, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , subsidiary Phyto Animal Health today announced the ...
PR Newswire2 months ago
Medical Marijuana, Inc. Subsidiary HempMeds® and Charitable Partner ECHO Connection Announce Sponsorship of Harper's Heroes First Annual Gala
SAN DIEGO, April 23, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds®, alongside charitable partner ECHO Connection, will sponsor Harper's Heroes First Annual Gala in Dallas, Texas on Saturday, April 27. "At HempMeds, we believe in doing everything we can to improve the health and wellness of all," said HempMeds® President Todd Morrow. The Hope4Harper Foundation was created in memory of Harper Elle Howard, the little girl with CDKL5 epilepsy who helped bring medical marijuana to Latin America, and lost her battle to a CDKL5 disorder on Jan. 8, 2016.